Bliss GVS Pharma Limited — Board Meeting, 10-02-2026: Outcome of Board Meeting

Bliss GVS Pharma's Board approved consolidated financial results for the quarter and nine months ended December 31, 2025. They also declared an interim dividend of 50% (0.50 paisa per equity share) for FY26. The record date for this dividend is February 18, 2026.